Dec 16, 2014 ... On November 22, 2011, the Department of Justice filed a one-count criminal information against Merck Sharp & Dohme, charging the company ...
Aug 6, 2015 ... v. MERCK SHARP & DOHME CORP.,. Defendant-Appellee. No. 15-55874. D.C. No. .... developed by Merck Sharp & Dohme Corporation.
Mar 17, 2016 ... Merck Sharp & Dohme Corp., Defendant, represented by Michael P. Kelly, ... the defendant Merck & Co., Inc. and Merck Sharp & Dohme Corp., ...
MERCK SHARP & DOHME CORP. v. ACTAVIS LABORATORIES FL, INC. et al. 3: 15-cv-06075; Filed: 08/06/2015; Case Updated Daily; Latest Docket Entry: ...
MERCK SHARP & DOHME CORP. v. BRISTOL-MYERS SQUIBB CO. et al. 3:16- cv-02122; Filed: 04/15/2016; Closed: 03/14/2017; Latest Docket Entry: 04/18/ ...
Sanofi-Aventis U.S. LLC et al v. Merck Sharp & Dohme Corp. 1:16-cv-00812; Filed: 09/16/2016; Case Updated Daily; Latest Docket Entry: 04/18/2017; PACER .
Nov 3, 2014 ... Merck, Sharp & Dohme Corp. and Bristol-Myers Squibb Pharmaceuticals Ltd v Teva Pharma B.V. and Teva UK Ltd, England & Wales High ...
Apr 27, 2015 ... This post comes only from the Cozen O'Connor side of the blog. The Vioxx MDL ... But, if Levitt v. Merck Sharp & Dohme Corp., 2015 U.S. Dist.
May 20, 2000 ... ``In the case of Merck, Sharp & Dohme,'' he wrote, ``the factory complex does not meet ... Dublin Corporation Bye-Laws and the requirements of the Minister for Local Government. ... was no reason to refer to the case of Hanrahan v Merck, Sharp & Dohme. .... Eden Quay in Dublin Photo: Douglas O'Connor ...
Nov 11, 2011 ... (1)Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA. ... greater with rizatriptan compared with placebo (55.0% vs 17.4%, P < .001).